中新健康 | 国家过敏性疾病临床研究大数据平台启动
中新网北京5月25日电 日前，协和过敏春季论坛暨北京慢性病防治与健康教育研究会变态反应学专业委员会第二届过敏性疾病防治与健康教育论坛在北京举行。会上，由国家皮肤与免疫疾病临床医学研究中心-过敏性疾病临床研究中心建设的国家过敏性疾病临床研究大数据平台正式启动。
该平台旨在整合国内过敏性疾病临床研究资源，通过大数据分析，更好地理解过敏性疾病的发生机制，为临床诊疗提供科学依据。平台的建设将促进过敏性疾病领域的科研成果转化，为患者提供更加精准的治疗方案。
在论坛上，来自全国各地的过敏性疾病专家共同探讨了过敏性疾病防治的新策略，分享了最新的研究成果。与会专家一致认为，过敏性疾病是当前公共卫生领域面临的重大挑战之一，需要社会各界的共同努力。
国家过敏性疾病临床研究大数据平台的启动，标志着我国在过敏性疾病研究领域迈出了重要一步。通过这一平台，将有助于提升我国在过敏性疾病领域的国际影响力，为全球过敏性疾病防治贡献中国智慧和中国方案。
英语如下：
Title: “National Allergy Big Data Platform Launched”
Keywords: Allergy Research, Clinical Big Data, Health Education
Content:
Health China | Launch of National Allergy Diseases Clinical Research Big Data Platform
Beijing, May 25th, 2023 – Recently, the Harmonious Allergy Spring Forum and the Second Allergy Diseases Prevention and Health Education Forum of the Special Committee on Allergic Diseases of the Beijing Chronic Disease Prevention and Health Education Research Association were held in Beijing. At the event, the National Allergy Diseases Clinical Research Big Data Platform, which is under the construction of the National Clinical Research Center for Dermatology and Immunology – Allergy Diseases Clinical Research Center, was officially launched.
The platform aims to integrate domestic clinical research resources for allergy diseases, better understanding the mechanisms of their occurrence through big data analysis, and providing scientific evidence for clinical diagnosis and treatment. The construction of the platform will promote the transformation of scientific research achievements in the field of allergy diseases, offering more precise treatment plans for patients.
At the forum, experts on allergy diseases from across the country discussed new strategies for the prevention and treatment of allergy diseases and shared the latest research findings. The experts unanimously agreed that allergy diseases are one of the major challenges in the current public health field and require the joint efforts of all sectors of society.
The launch of the National Allergy Diseases Clinical Research Big Data Platform marks an important step forward in the research field of allergy diseases in China. Through this platform, it will help enhance China’s international influence in the field of allergy diseases, contributing Chinese wisdom and solutions to global allergy disease prevention and treatment.
【来源】http://www.chinanews.com/life/2024/05-25/10223116.shtml
Views: 8